ANCA-Negative Granulomatosis with Polyangiitis Presenting with Hypertrophic Cranial Pachymeningitis, Abducens Nerve Palsy, and Stenosis of the Internal Carotid Artery

Harabuchi, Shohei; Bandoh, Nobuyuki; Yasukawa, Rika; Kono, Michihisa; Goto, Takashi; Harabuchi, Yasuaki; Ikeda, Hidetoshi; Kamada, Hajime; Nishihara, Hiroshi

doi:https://doi.org/10.1155/2017/9687383

Case Reports in Otolaryngology

On this page

Abstract Introduction Case Report Discussion Conclusion Ethical Approval Consent Conflicts of Interest Authors’ Contributions References Copyright Related Articles

Case Report | Open Access

Volume 2017 | Article ID 9687383 | https://doi.org/10.1155/2017/9687383

ANCA-Negative Granulomatosis with Polyangiitis Presenting with Hypertrophic Cranial Pachymeningitis, Abducens Nerve Palsy, and Stenosis of the Internal Carotid Artery

Shohei Harabuchi,^1,2Nobuyuki Bandoh ,¹Rika Yasukawa,^1,2Michihisa Kono,¹Takashi Goto,¹Yasuaki Harabuchi,²Hidetoshi Ikeda,³Hajime Kamada,³and Hiroshi Nishihara⁴

Academic Editor: M. Tayyar Kalcioglu

Received02 Jun 2017

Revised10 Oct 2017

Accepted17 Oct 2017

Published30 Nov 2017

Abstract

We report a rare case of granulomatosis with polyangiitis (GPA) presenting with hypertrophic cranial pachymeningitis (HCP), abducens nerve palsy, and stenosis of the internal carotid artery (ICA). A 59-year-old Japanese man presented with a year history of nasal obstruction and a 2-month history of slight headache. Histopathological examination of the granulomatous mucosa in the ethmoid sinuses resected by endoscopic sinus surgery revealed necrotizing vasculitis with multinucleated giant cells. The patient was diagnosed with the limited form of GPA as a result of the systemic examination. He declined immunosuppressive treatment. Eighteen months after the diagnosis of GPA, he presented with diplopia and severe headache. Though nasal findings indicating GPA were not observed in the nasal cavity, CT scan revealed a lesion of the right sphenoid sinus eroding the bone of the clivus. Gadolinium-enhanced MRI of the brain showed thickening of the dura mater around the right cavernous sinus and clivus. Magnetic resonance angiography and cerebral angiography revealed narrowing at the C5 portion of the ICA. Intravenous methylprednisolone pulse therapy followed by oral prednisolone and cyclophosphamide resolved headache and dramatically improved HCP and stenosis of the ICA.

1. Introduction

Granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis, is a systemic autoimmune disease involving small- to medium-sized vasculitis and necrotizing granulomatous inflammation in the upper and lower respiratory tract, as well as the kidney. Central nervous system (CNS) involvement is uncommon, occurring in 4–18% of GPA patients [1, 2], and characterized by hypertrophic cranial pachymeningitis (HCP) [3, 4], cranial nerve paralysis [4], cerebral infarction [5–7], and subarachnoid hemorrhage [8, 9]. Here, we report a rare case of GPA presenting with HCP, abducens nerve palsy, and stenosis of the internal carotid artery (ICA).

2. Case Report

A 59-year-old Japanese man presented with a year history of nasal obstruction and a 2-month history of slight headache. Nasal examination showed swelling and crust formation of the bilateral inferior turbinate. CT scan revealed swelling of the mucosa in the bilateral ethmoid sinuses and soft-tissue filling in the right sphenoid sinus (Figures 1(a) and 1(b)). We initially diagnosed chronic rhinosinusitis and performed endoscopic sinus surgery (ESS) under general anesthesia. We opened the bilateral ethmoid and the sphenoid sinuses. During ESS, easy bleeding and granulomatous mucosa in the bilateral ethmoid sinuses was seen and resected (Figures 2(a) and 2(b)). Histopathological examination of the mucosa revealed necrotizing vasculitis with multinucleated giant cells (Figures 3(a) and 3(b)). We then examined the patient systemically. Brain MRI and chest CT scan showed no abnormal finding. Urinalysis revealed neither hematuria nor proteinuria. Bilateral ear drums were normal. No hearing or visual loss was identified. Negative results for serum proteinase 3- (PR3-) and myeloperoxidase- (MPO-) anti-neutrophil cytoplasm antibody (ANCA) were obtained from fluorescence enzyme immunoassay (FEIA). We diagnosed the limited form of GPA. Shortly after making this diagnosis, the headache resolved and nasal obstruction disappeared. The patient declined immunosuppressive treatment for fear of worsening of his diabetes mellitus. We started careful follow-up every 3 months.

(a)

(b)

(a)

(b)

(a)

(b)

Eighteen months after the diagnosis of GPA, the patient presented with diplopia and sudden onset of severe right-sided headache. Nasal endoscopic examination revealed only slight edematous mucosa in the bilateral nasal cavity and the ethmoid sinus. The opening of the right sphenoid sinus was closed by the granulation covered with mucosa, and we could not look into the inside of the sinus. CT scan revealed a lesion of the right sphenoid sinus eroding the bone of the clivus and thickening of the dura mater (Figures 4(a) and 4(b)). Gadolinium-enhanced MRI of the brain showed thickening of the dura mater around the right cavernous sinus and clivus (Figures 5(a) and 5(b)). Magnetic resonance angiography (MRA) and cerebral angiography revealed narrowing at the C5 portion of the ICA (Figures 5(a)–5(d)). Results for serum PR3- and MPO-ANCA were negative. We diagnosed HCP and right abducens nerve palsy, and stenosis of the intracranial ICA due to GPA extension. The patient did not show ischemic attack. Intravenous methylprednisolone (mPSL) pulse therapy was administered at 1g/day for 3 days, followed by oral prednisolone (PSL) at 30 mg/day and cyclophosphamide (CY) at 50 mg/day. The PSL dose was gradually tapered. The headache disappeared immediately. One year after the initiation of the treatment, the patient showed slight saddle nose deformity but did not complain of nasal pain and obstruction. Brain MRI and MRA showed a reduction in the thickness of the dura mater and improved blood flow in the ICA (Figures 5(e)–5(g)). Although the patient still has right abducens nerve palsy, he has not complained of headache for 2 years under a medication with oral PSL at 7 mg/day and azathioprine at 25 mg/day.

(a)

(b)

(a)

(b)

(c)

(d)

(e)

(f)

(g)

Figure 5

Imaging studies before immunosuppressive treatment (a–d) and 2 years after the initiation of the treatment (e–g). Gadolinium-enhanced T1-weighted MRI of the brain reveals thickening of enhanced dura mater extending from the cavernous sinus to the clivus on axial (a) and coronal (b) images (triangle). Narrowing at the C5 portion of the internal carotid artery (ICA) is apparent on axial (a) and coronal (b) MRI, MRA (c), and lateral cerebral angiography of the ICA (d) (arrow). Thickening of the dura mater and stenosis of the ICA improved on axial (e) and coronal (f) MRI and MRA (g).

3. Discussion

This report highlights a unique case of GPA with CNS involvement. First, the patient was diagnosed with not only HCP around the cavernous sinus and right abducens nerve palsy but also stenosis of the intracranial ICA due to extension of GPA from the paranasal sinus. Second, neither serum PR3-ANCA nor MPO-ANCA has been detected at any stage during the course. Third, this patient with HCP, stenosis of the ICA, and headache was successfully treated with immunosuppressive treatment without causing ischemic attack or cerebral infarction. HCP, which occurs in 0.6–8% of GPA patients [1, 2], is characterized by localized or diffuse thickening of the intracranial dura mater [4]. Gadolinium-enhanced MRI is the most useful diagnostic technique for the detection of HCP. HCP is most commonly seen in the falx cerebri and tentorium cerebelli and is rare around the cavernous sinus [1]. Cranial nerve paralysis occurs in about 50% of GPA patients with HCP. The II, III, V, VI, VII, and X cranial nerves are predominantly affected [4, 10]. To the best of our knowledge, only 12 cases with GPA accompanied by cerebrovascular disorder, including the present case, have been reported in the literature as summarized in Table 1 [3, 5–9, 11–13]. Headache was the most common symptom and reported in 7 (58%) of 12 cases. HCP and nose, ear, eye, renal, and lung involvement were shown in 7 (58%) and 7 (58%), 5 (42%), 7 (58%), 6 (50%), and 4 (33%) of 12 cases, respectively. Only 2 cases showed intracranial ICA stenosis accompanied by HCP around the cavernous sinus and cranial nerve paralysis like the present case [11, 12].

CNS involvement in GPA is explained by any combination of 3 possible mechanisms: (i) direct extension from nasal and paranasal sinuses to adjacent structures; (ii) vasculitis of the CNS; and (iii) formation of remote granulomatous lesions in the CNS [14]. In the present case, we suspected that both direct extension of inflammation and vasculitis spread out from the ethmoid and sphenoid sinuses to the cavernous sinus, dura mater, and abducens nerve. Narrowing of the ICA was supposed to be caused by luminal stenosis by vasculitis as well as compression of the surrounding thickened dura mater.

GPA is usually associated with serum PR3- or MPO-ANCA, with the sensitivity and specificity of more than 95% in patients with active generalized GPA [15]. ANCA titer offers an indicator of disease activity or relapse after treatment [4]. There have been a certain number of case reports regarding GPA patients who were negative for both MPO- and PR3-ANCAs. The 2012 Chapel Hill consensus conference definitions proposed ANCA-negative ANCA-associated vasculitis caused by three possibilities: (i) ANCA that cannot be detected by current methods; (ii) ANCA of as yet undiscovered specificity; and (iii) pathological mechanisms not involving ANCA [16]. We cannot exclude the third possibility but can nominate the former two possibilities as candidates. A large-scale study has shown that 83% of ANCA-negative GPA patients show severe CNS involvement, whereas only 10% of all the GPA patients have CNS involvement [1], suggesting that GPA patients with serum ANCA negativity are closely associated with CNS involvement [1].

In the present case, the opportunity to identify HCP and stenosis of the ICA was missed for eighteen months, because we had considered the GPA status of the patient to be stable due to the lack of symptoms and of nasal findings indicating GPA at scheduled follow-up and ANCA negativity. Closure of the opening of the right sphenoid sinus may have worsened the granulomatous inflammation in the sinus and delayed the detection of the disease extension by nasal endoscopy. Ischemic attack was able to be prevented in advance by treatment with mPSL pulse therapy followed by oral PSL and CY. Rapid disease remission can be achieved by any of the treatment strategies that include mPSL pulse therapy, PSL, CY, plasma exchange, and rituximab [2, 4]. Patients with GPA need maintenance treatment with PSL and other immunosuppressive agents such as azathioprine and methotrexate to avoid relapses for a long period [14]. GPA usually has a chronic relapsing and remitting course. Careful follow-up with nasal endoscopic examination, CT scan, and MRI is necessary to find out the progression of GPA and any side effects by immunosuppressive agents.

4. Conclusion

HCP and cerebrovascular disorder must be taken into consideration when a patient with GPA present with severe headache and cranial nerve paralysis. Gadolinium-enhanced MRI is quite useful for the diagnosis and follow-up of HCP. The combination of corticosteroid and immunosuppressant is required for induction and remission in patients with GPA.

Ethical Approval

This is a retrospective and observational case report and is not applicable for the ethics committee approval.

Written informed consent for publication of clinical details and images was obtained from the patient.

Conflicts of Interest

The authors declare that there are no actual or potential conflicts of interest in relation to this article.

Authors’ Contributions

Shohei Harabuchi and Nobuyuki Bandoh contributed equally to this work.

References

E. Reinhold-Keller, K. de Groot, K. Holl-Ulrich et al., “Severe CNS manifestations as the clinical hallmark in generalized Wegener’s granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature,” Clinical and Experimental Rheumatology, vol. 19, no. 5, pp. 541–549, 2001.
View at: Google Scholar
V. Higuera-Ortiz, A. Reynoso, N. Ruiz, R. D. Delgado-Hernández, G. Gómez-Garza, and L. F. Flores-Suárez, “Pachymeningitis in granulomatosis with polyangiitis: case series with earlier onset in younger patients and literature review,” Clinical Rheumatology, vol. 36, no. 4, pp. 919–924, 2017.
View at: Publisher Site | Google Scholar
A. G. Fam, E. Lavine, L. Lee, B. Perez-Ordonez, and M. Goyal, “Cranial pachymeningitis: an unusual manifestation of Wegener’s granulomatosis,” Journal of Rheumatology, vol. 30, no. 9, pp. 2070–2074, 2003.
View at: Google Scholar
A. Yokoseki, E. Saji, M. Arakawa et al., “Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody,” Brain, vol. 137, no. 2, pp. 520–536, 2014.
View at: Publisher Site | Google Scholar
M. R. Sivakumar and A. Chandrakantan, “A rare case of stroke in Wegener’s granulomatosis,” Cerebrovascular Diseases, vol. 13, no. 2, pp. 143-144, 2002.
View at: Publisher Site | Google Scholar
W. Peng and X. Wang, “Hypertrophic pachymeningitis and cerebral infarction resulting from ANCA-associated vasculitis,” Neurology India, vol. 60, no. 4, pp. 424–426, 2012.
View at: Publisher Site | Google Scholar
R. Yajima, Y. Toyoshima, Y. Wada et al., “A fulminant case of granulomatosis with polyangiitis with meningeal and parenchymal involvement,” Case Reports in Neurology, vol. 7, no. 1, pp. 101–104, 2015.
View at: Publisher Site | Google Scholar
D. N. Cruz and A. S. Segal, “A patient with Wegener’s granulomatosis presenting with a subarachnoid hemorrhage: case report and review of CNS disease associated with Wegener’s granulomatosis,” American Journal of Nephrology, vol. 17, no. 2, pp. 181–186, 1997.
View at: Publisher Site | Google Scholar
H. Takei, Y. Komaba, H. Kitamura et al., “Aneurysmal subarachnoid hemorrhage in a patient with Wegener’s granulomatosis,” Journal of Clinical and Experimental Nephrology, vol. 8, no. 3, pp. 274–278, 2004.
View at: Publisher Site | Google Scholar
Y. H. Huang, L. S. Ro, R. K. Lyu et al., “Wegener’s granulomatosis with nervous system involvement: a hospital-based study,” European Neurology, vol. 73, no. 3-4, pp. 197–204, 2015.
View at: Publisher Site | Google Scholar
T. Nagashima, S. Maguchi, Y. Terayama et al., “P-ANCA-positive Wegener’s granulomatosis presenting with hypertrophic pachymeningitis and multiple cranial neuropathies: case report and review of literature,” Neuropathology, vol. 20, no. 1, pp. 23–30, 2000.
View at: Publisher Site | Google Scholar
P. Thajeb and J. J. Tsai, “Cerebral and oculorhinal manifestations of a limited form of Wegener’s granulomatosis with c-ANCA-associated vasculitis,” Journal of Neuroimaging, vol. 11, no. 1, pp. 59–63, 2001.
View at: Publisher Site | Google Scholar
O. Weijtens, N. Mooy, and D. Paridaens, “Horner’s syndrome as manifestation of Wegener’s granulomatosis,” Eye, vol. 18, no. 8, pp. 846–848, 2004.
View at: Publisher Site | Google Scholar
Y. Harabuchi, K. Kishibe, K. Tateyama et al., “Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): a retrospective analysis of 235 patients from a nationwide survey in Japan,” Modern Rheumatology, vol. 27, no. 1, pp. 87–94, 2017.
View at: Publisher Site | Google Scholar
K. de Groot, D. K. Schmidt, A. C. Arlt, W. L. Gross, and E. Reinhold-Keller, “Standardized neurologic evaluations of 128 patients with Wegener granulomatosis,” Archives of Neurology, vol. 58, no. 8, pp. 1215–1221, 2001.
View at: Publisher Site | Google Scholar
J. C. Jennette, R. J. Falk, P. A. Bacon et al., “2012 revised international chapel hill consensus conference nomenclature of vasculitides,” Arthritis and Rheumatism, vol. 65, no. 1, pp. 1–11, 2013.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2017 Shohei Harabuchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

2026

Downloads

886

Citations